Protealis is based in Ghent, Belgium. It has raised $37M in total funding. Latest round: Series B.
Protealis funding overview
Protealis is based in Ghent, Belgium. Protealis has raised $37M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Protealis runs through 2024; nothing later has been disclosed. Investors on record include V-Bio Ventures, Innovation Industries, Agri Investment Fund (AIF), Korys, Participatie-maatschappij Vlaanderen (PMV), Estari Group and 5 others. 11 distinct backers are named across the disclosed rounds.
Protealis has raised $37M in total disclosed funding across the rounds on record.
Who has invested in Protealis?
V-Bio Ventures, Innovation Industries, Agri Investment Fund (AIF), Korys, Participatie-maatschappij Vlaanderen (PMV), Estari Group are named among the investors backing Protealis.
What was the latest Protealis funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Protealis based?
Protealis is based in Ghent, Belgium.
When did Protealis last raise?
The last disclosed Protealis round closed in January 2024 at Series B.
Every Protealis figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Ghent at a similar stage.
